Vivo Capital, LLC - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 101 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 2.0%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q1 2021$3,282,000
-18.8%
140,2980.0%0.12%
-36.1%
Q4 2020$4,041,000
+42.2%
140,2980.0%0.18%
+9.8%
Q3 2020$2,842,000
-32.6%
140,2980.0%0.16%
-45.7%
Q2 2020$4,216,000
-4.4%
140,2980.0%0.30%
-24.3%
Q1 2020$4,410,000140,2980.40%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q1 2020
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders